Third Harmonic Bio Inc (THRD) Annual Balance Sheets

Annual · GAAP · USD millions
Access THRD quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Third Harmonic Bio Inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent285.06
Cash & Short-term Investments285.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.48
Total Current Assets290.54
Equipment/Property/Plant Net0.13
Other Assets, Noncurrent1.00
Restricted Cash Noncurrent0.45
Operating Lease Right Of Use Asset3.04
Total Assets294.61
Liabilities
Accounts Payable, Current AC1.94
Other Liabilities, Current5.17
Total Current Liabilities7.11
Total Long-term Debt0.00
Other liabilities, Noncurrent2.35
OperatingLeaseLiabilityNoncurrent2.35
Accrued Expense And Other Current Liabilities4.31
Total Liabilities9.46
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock444.83
Retained Earnings / Accumulated Deficit-159.69
Other Equity0.00
Common Stockholder's Equity285.15
Total Stockholder's Equity285.15
Liabilities & Stockholder's Equity294.61
4 historic quarters locked

Sign in to unlock the full Third Harmonic Bio Inc balance sheet history.

About Third Harmonic Bio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-045736

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License